Is brain perfusion a differentiating factor between Parkinson’s Disease (PD) and Progressive Supranuclear Palsy – Parkinsonism Predominant (PSP-P)?
Objective: Parkinson’s Disease – Postural Instability Gait Disorder (PD-PIGD) and Progressive Supranuclear Palsy – Parkinsonism Predominant (PSP-P) are entities affected by difficulties in differentiation in…Serum neurofilament light chain differentiates early Parkinson’s disease from progressive supranuclear palsy-parkinsonism
Objective: To assess the value of serum neurofilament light chain (NFL) levels in differentiating parkinsonian syndromes. Background: The diagnosis of Parkinson’s disease (PD) mostly relies…Cognitive Differences Between Men and Women with Progressive Supranuclear Palsy
Objective: (1) To evaluate the cognitive differences between men and women with progressive supranuclear palsy (PSP) and (2) to investigate whether sex has an effect…Inertial sensor-based kinematics in the differential diagnosis of Parkinson’s disease and atypical parkinsonisms
Objective: Assess the role of inertial sensors in the phenotyping and differential diagnosis of Parkinson’s Disease vs. Atypical Parkinsonisms Background: Wearable devices have been used…Midbrain/pons area ratio and clinical features predict the prognosis of Progressive Supranuclear Palsy
Objective: This retrospective study aims to characterize the natural history of PSP and to find predictors of shorter survival and faster decline of activity of…Correlations between amantadine usage, gait, and cognition in PSP: a post hoc analysis of the davunetide trial
Objective: Amantadine anecdotally improves gait and balance in PSP, potentially by increasing alertness, but there are no definitive data to support this observation. We investigated…Photophobia and Progressive Supranuclear Palsy
Objective: To characterize the prevalence, symptoms, and severity of light sensitivity in Progressive Supranuclear palsy (PSP)). Background: Photophobia is a commonly encountered clinical symptom in…MRI evaluation of Progressive Supranuclear Palsy
Objective: We aimed to evaluate the magnetic resonance imaging-derived parameters in differentiation of patients with progressive supranuclear palsy from patients with Parkinson’s disease and other…Decline in the midbrain-to-pons ratio over one year can support the differentiation between PSP and IPD
Objective: The midbrain-to-pons ratio (MTPR) is considered as an important diagnostic biomarker to differentiate between progressive supranuclear palsy (PSP) and idiopathic Parkinson’s disease (IPD). Here,…Diagnostic accuracy of MR planimetry in clinically unclassifiable parkinsonism
Objective: To determine diagnostic accuracy of P/M, MRPI, and new indices termed P/M2.0 and MRPI2.0 (multiplying P/M and MRPI by third ventricle width/frontal horns width…
- « Previous Page
- 1
- …
- 15
- 16
- 17
- 18
- 19
- …
- 38
- Next Page »